Scientific Program
-
-
08:30 - 10:40 Controversies in Male Reproductive Medicine
Chairs: S. Luján, Spain / C. Niederberger, USA08:30 - 08:40 Introduction
C. Niederberger, USA08:40 - 09:00 Evaluate the male: need or useless?
J. Hotaling, USA09:00 - 09:10 Questions and answers 09:10 - 09:30 Pre-TESE: natural or stimulated spermatogenesis?
C. Niederberger, USA09:30 - 09:40 Questions and answers 09:40 - 10:00 To choose and process sperm for ART (What to do and not do)
M. Meseguer, Spain10:00 - 10:10 Questions and answers 10:10 - 10:30 Reconstructive surgery of the male: when and how to cut
S. Luján, Spain10:30 - 10:40 Questions and answers 10:40 - 11:10 COFFEE BREAK 11:10 - 13:10 Controversies in Male Reproductive Medicine
Chairs: N. Garrido, Spain / M. Meseguer, Spain11:10 - 11:30 Extraction of sperm: what is the best way?
C. Niederberger, USA11:30 - 11:40 Questions and answers 11:40 - 12:00 To evaluate sperm in the laboratory: what is real and what is science fiction?
N. Garrido, Spain12:00 - 12:10 Questions and answers 12:10 - 12:30 Functional sperm from stem cells
J. Medrano, Spain12:30 - 12:40 Questions and answers 12:40 - 13:00 The future: what can we imagine?
J. Hotaling, USA13:00 - 13:10 Questions and answers
-
-
-
13:45 - 14:00 Opening Ceremony 14:00 - 16:00 Ovarian Stimulation
Chairs: J.A. García Velasco, Spain / A. Ruiz, Spain14:00 - 14:30 New concepts of ovarian stimulation: where are we today?
B. Fauser, Netherlands14:30 - 15:00 Avoiding the LH surge: analogues vs progesterone
D. Kaser, USA15:00 - 15:30 Duo Stim: a critical appraisal
F. Ubaldi, Italy15:30 - 16:00 How intense should we stimulate the ovaries?
N. Polyzos, Spain16:00 - 16:30 COFFEE BREAK 16:30 - 18:00 Premature Ovarian Insufficiency
Chairs: E. Labarta, Spain / G. Castillón, Spain
16:30 - 17:00 Genetics of premature ovarian insufficiency
A. Rajkovic, USA17:00 - 17:30 Ovarian fragmentation for follicular activation (OFFA)
C. Díaz, Spain17:30 - 18:00 Autologous stem cells for ovarian insufficiency
S. Herraiz, Spain18:00 - 19:00 CONTROVERSY: individualized ovarian stimulation: feasible or not?
Chairs: F. Olivennes, France / S. Soares, Portugal
Feasible position: E. Bosch, Spain vs. Not feasible position: C. van Tilborg, Netherlands19:00 -19:45 Industry Supported Symposia: MERCK
CONTROLLING DETAILS IN ART: THE PATH TO OPTIMISE CLINICAL OUTCOMES19:00-19:05 Introduction & closing.
J. Serna, Spain19:05-19:25
Optimising clinical and management efficiencies in art.
R. Aurell, Spain19:25-19:45
Technological solutions to maximise compliance in the embryology lab.
R. Holmes, USA19:45-20:30 Welcome reception
Exhibition Area
-
-
-
08:00 - 10:00 Implantation
Chairs: A. Salazar, Spain / B. Fauser, Netherlands08:00 - 08:30 Implantation failure: the embryo vs the endometrium
N. Macklon, UK08:30 - 09:00 Role of immune system in improving implantation
D. Alecsandru, Spain09:00 - 09:30 Microbiome and human reproduction: current status
C. Simón, Spain09:30 - 10:00 How parental weight excess affects reproduction
J. Bellver, Spain10:00 - 10:30 COFFEE BREAK 10:30 - 12:00 Surgery
Chairs: E. Bosch, Spain / K. Nouri, Austria10:30 - 11:00 Diagnosis of uterine malformations with an impact on ART
S. Vannuccini, Italy11:00 - 11:30 New approaches to thin endometrium
M. Ferrando, Spain11:30 - 12:00 Routine hysteroscopy before IVF: does it help?
Y. Khalaf, UK12:00 - 13:00 CONTROVERSY: Deep endometriosis – surgery vs ART
Chairs: D. de Ziegler, France / M. Fernández, Spain
Surgery position: H. Roman, France vs Art position: J. Serna, Spain13:00 - 13:30 INTERNATIONAL IVI FOUNDATION RESEARCH AWARDS PRESENTATION 13:30 - 14:30 LUNCH 14:30 - 16:30 Hot topics I
Chairs: J. Krüssel, Germany / A. Requena, Spain
Session sponsored by14:30 - 15:00 Is freeze-all really better?
A. Pinborg, Denmark15:00 - 15:30 Prepubertal fertility preservation: state of the art
R. Anderson, UK15:30 - 16:00 Should we freeze ovarian tissue or oocytes for fertility preservation?
A. Pellicer, Spain16:00 - 16:30 Optimal cycle regimen for frozen embryo replacement
H. Fatemi, UAE16:30 - 17:00 COFFEE BREAK 17:00 - 18:30 Hot topics II
Chairs: C. Colomé, Spain / H. Fatemi, UAE17:00 - 17:30 Pragmatic approach to the infertile PCO patient
N. Macklon, UK17:30 - 18:00 Mitochondrial DNA quantity as a biomarker
E. Fragouli, UK18:00 - 18:30 Nuclear transfer: new data and new indications
G. Calderón, Spain18:30 - 19:30 CONTROVERSY: Should we transfer mosaic embryos in 2019?
Chairs: R. Fanchin, France / F. Bronet, Spain
Yes position: F. Fiorentino, Italy vs No position: R. Scott, USA -
08:00 - 10:00 Parallel Session - Embryology
Chairs: F. Bronet, Spain / M. Florensa, Spain08:00 - 08:30 Embryo metabolism: past, present and future
D. Sakkas, USA08:30 - 09:00 Artificial intelligence to enhance time lapse
C. Hickman, UK09:00 - 09:30 Extracellular vesicles and their clinical application
R. Scott, USA09:30 - 10:00 Non invasive PGS: reality or dream?
E. Fragouli, UK10:00 - 10:30 COFFEE BREAK 10:30 - 12:00 Parallel session - Epigenetics and Aging
Chairs: N. Garrido, Spain / M. Torres, Spain10:30 - 11:00 Epigenetics – parental impact on the embryo
S. Laurentino, Germany11:00 - 11:30 Impact of telomeres damage in ovarian aging
E. Varela, Spain11:30 - 12:00 Epigenetics, telomeres and other genetic factors impacting assisted reproduction
D. Wells, UK
-
-
-
08:30 - 10:00 Male factor
Chairs: C. González, Spain / A. Pacheco, Spain08:30 - 09:00 What to test in the male beyond classical sperm analysis
S. Luján, Spain09:00 - 09:30 Association of male factor infertility with somatic health
C. Niederberger, USA09:30 - 10:00 Microfluidic sperm sorting
J. Hotaling, USA10:00 -10:45 Industry Supported Symposia: FERRING
Ovarian stimulation: Treating the extremes10:00–10:02 Welcome and introduction
S. Lavery, UK10:02–10:22 Improving outcomes in poor responders: Quality vs quantity
N. Polyzos, Spain10:22–10:42 Balancing safety with efficacy: A measured approach to ovarian stimulation in high responders
F. Cruz, Spain10:42–10:45 Closing remarks
S. Lavery, UK10:45 - 11:15 COFFEE BREAK 11:15 - 13:45 Future directions
Chairs: C. Niederberger, USA / A. Pellicer, Spain11:15 - 11:45 Gene editing using CRISPR/Cas
G. Marfany, Spain11:45 - 12:15 Premise, pitfalls and regulation of human genome editing
K. Orwig, USA12:15 - 12:45 Correction of disease causing mutations in preimplantation embryos
D. Wells, UK12:45 - 13:15 Contribution of corpus luteum number to maternal vascular health and preeclampsia risk
F. von Versen-Höynck, Germany13:15 - 13:45 Breakthrough lecture: Investigating cellular and molecular interactions at the maternal/fetal interface that mediate placentation
A. Moffett, UK
-